ASX - Delayed Quote AUD

PharmX Technologies Limited (PHX.AX)

0.0300 0.0000 (0.00%)
At close: April 22 at 10:15 AM GMT+10
Key Events
Loading Chart for PHX.AX
DELL
  • Previous Close 0.0300
  • Open 0.0300
  • Bid 0.0300 x --
  • Ask 0.0410 x --
  • Day's Range 0.0300 - 0.0300
  • 52 Week Range 0.0120 - 0.0530
  • Volume 286,950
  • Avg. Volume 392,361
  • Market Cap (intraday) 17.955M
  • Beta (5Y Monthly) 1.39
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Feb 22, 2024
  • Forward Dividend & Yield 0.01 (25.00%)
  • Ex-Dividend Date Nov 28, 2023
  • 1y Target Est --

PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. The company's network connects retail pharmacy and suppliers in Australia and New Zealand. It operates PharmX, an electronic pharmacy ordering gateway; and PharmXchange, a digital sales and marketing platform integrated with PharmX for pharmacies and their suppliers. The company was formerly known as Corum Group Limited and changed its name to PharmX Technologies Limited in October 2023. PharmX Technologies Limited was incorporated in 1950 and is headquartered in Sydney, Australia.

pharmx.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: PHX.AX

Performance Overview: PHX.AX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PHX.AX
26.83%
S&P/ASX 200 [XJO]
0.20%

1-Year Return

PHX.AX
6.79%
S&P/ASX 200 [XJO]
3.55%

3-Year Return

PHX.AX
61.50%
S&P/ASX 200 [XJO]
7.53%

5-Year Return

PHX.AX
43.70%
S&P/ASX 200 [XJO]
18.64%

Compare To: PHX.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PHX.AX

Valuation Measures

Annual
As of 4/28/2024
  • Market Cap

    17.96M

  • Enterprise Value

    5.81M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    1.12

  • Enterprise Value/Revenue

    0.96

  • Enterprise Value/EBITDA

    37.21

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -35.22%

  • Return on Assets (ttm)

    1.20%

  • Return on Equity (ttm)

    1.36%

  • Revenue (ttm)

    6.28M

  • Net Income Avi to Common (ttm)

    263k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.44M

  • Total Debt/Equity (mrq)

    1.81%

  • Levered Free Cash Flow (ttm)

    6.65M

Company Insights: PHX.AX

People Also Watch